Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neumora Therapeutics, Inc. - Common Stock (NQ: NMRA ) 13.21 +0.29 (+2.24%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Neumora Therapeutics, Inc. - Common Stock < Previous 1 2 Next > Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders August 14, 2024 Roundtable discussion to take place on Thursday, September 12 at 8:00 a.m. ET From Neumora Therapeutics, Inc. Via GlobeNewswire NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q2 2024 August 06, 2024 NMRA stock results show that Neumora Therapeutics met analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update August 06, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation June 20, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression May 14, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q1 2024 May 07, 2024 NMRA stock results show that Neumora Therapeutics met analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 07, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics to Participate in Upcoming Conferences in May May 06, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March April 15, 2024 U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday. The Dow traded down 0.64% to 37,741.18 while the NASDAQ fell 1.68% to 15,902.96. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 15, 2024 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... Via Benzinga Crude Oil Down 1%; Charles Schwab Sales Top Estimates April 15, 2024 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 38,114.61 while the NASDAQ rose 0.07% to 16,187.02. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday? April 15, 2024 Neumora Therapeutics faces setbacks as FDA halts Phase 1 trial of NMRA-266 due to convulsion concerns in rabbits. Phase 1 study paused; company working with FDA for resolution. Via Benzinga Exposures Product Safety Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug April 15, 2024 The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect. Via Investor's Business Daily Why Is Mobile Global Esports (MGAM) Stock Down 18% Today? April 15, 2024 Mobile Global Esports stock is falling on Monday after the company revealed that shares of MGAM will be delisted later this week. Via InvestorPlace Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today? April 15, 2024 Neumora Therapeutics stock is falling on Monday as investors in NMRA shares react to a clinical trial being put on hold by the FDA. Via InvestorPlace Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session April 15, 2024 U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session April 15, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 15, 2024 We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning! Via InvestorPlace Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study April 15, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session March 13, 2024 Via Benzinga Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 13, 2024 Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24... Via Benzinga Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday March 13, 2024 U.S. stocks were mixed, with the Dow Jones index surging more than 100 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days March 13, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire NMRA Stock Earnings: Neumora Therapeutics Misses EPS for Q4 2023 March 07, 2024 NMRA stock results show that Neumora Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 07, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer January 22, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From Neumora Therapeutics, Inc. Via GlobeNewswire Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 22, 2023 Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 22, 2023 Via Benzinga Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday December 22, 2023 U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition... Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.